FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, namely to dermatology, and deals with dermal therapeutic composition for treatment of dermatitis, which contains sodiumuretic peptide of C-type (CNP) or sodiumuretic peptide of B-type (BNP) in quantity 1-500 mcg/g.
EFFECT: invention provides means for treatment of dermatitis, effective and safe in external application.
24 cl, 22 ex, 22 tbl, 20 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENT FOR TREATING RHINITIS | 2010 |
|
RU2502519C2 |
| METHOD FOR EVALUATING THE EFFICIENCY IN TREATING ATOPIC DERMATITIS IN CHILDREN | 2006 |
|
RU2317777C1 |
| METHOD FOR TREATING PATIENTS SUFFERING FROM ATOPIC DERMATITIS | 1995 |
|
RU2102054C1 |
| DIAGNOSTIC TECHNIQUE FOR ATOPIC DERMATITIS IN CHILDREN | 2011 |
|
RU2461828C1 |
| WAY OF TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2361604C1 |
| APPLICATION OF SEMAX PREPARATION FOR TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2347582C1 |
| METHOD OF ATOPIC DERMATITIS TREATMENT | 2006 |
|
RU2329837C2 |
| METHOD FOR PREDICTION OF RISK OF INFECTIOUS COMPLICATIONS DEVELOPMENT IN ATOPIC DERMATITIS | 2020 |
|
RU2738722C1 |
| METHOD FOR PREDICTION OF SEVERITY OF ATOPIC DERMATITIS IN CHILDREN | 2017 |
|
RU2677481C1 |
| METHOD OF TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2340348C1 |
